Advertisement

Related Videos

David A. Hyman, MD, JD, on Inclusive Shared Savings

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Varsha Gandhi, PhD, on Ibrutinib

Advertisement

Advertisement




Jul
10
Today In Oncology
Zanidatamab Plus Chemotherapy in Advanced HER2-Positive Gastroesophageal Adenocarcinoma
Women Aged 65 Plus Still at Heightened Risk of HPV-Related Cervical Cancer
Corticosteroids May Limit Efficacy of Immunotherapy in Patients With NSCLC
Optimizing the CAR to the Disease in B-Cell Malignancies
Study Supports Multi-Contaminant Water Treatment to Reduce Cancer Risk
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo